Article
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
International journal of cancer - 15 Feb 2023
Bahar-Shany Keren, Barnabas Georgina D, Deutsch Lisa, Deutsch Netanel, Glick-Saar Efrat, Dominissini Dan, Sapoznik Stav, Helpman Limor, Perri Tamar, Blecher Anna, Katz Guy, Yagel Itai, Rosenblatt Orgad, Shai Daniel, Brandt Benny, Meyer Raanan, Mohr-Sasson Aya, Volodarsky-Perel Alexander, Zilberman Itamar, Armon Shunit, Jakobson-Setton Ariella, Eitan Ram, Kadan Yfat, Beiner Mario, Josephy Dana, Brodsky Malka, Friedman Eitan, Anafi Liat, Molchanov Yossef, Korach Jacob, Geiger Tamar, Levanon Keren
Abstract excerpt
No current screening methods for high-grade ovarian cancer (HGOC) guarantee effective early detection for high-risk women such as germline BRCA mutation carriers. Therefore, the standard-of-care remains risk-reducing salpingo-oophorectomy (RRSO) around age 40. Proximal liquid biopsy is a promising source of biomarkers, but sensitivity has not yet qualified for clinical implementation. We aimed to develop a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
